Craft

Advanced
MorphoSys

MorphoSys

Revenue

€238.3 M

FY, 2023

MorphoSys Summary

Company Summary

Overview
MorphoSys is a biotechnology company focused on the research and development of fully human antibodies.
Type
Subsidiary
Status
Active
Founded
1992
HQ
Planegg, DE | view all locations
Website
http://www.morphosys.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Table of Contents

Key People

  • Malte Peters

    Malte Peters, Chief Research and Development Officer

    • Charlotte Lohmann

      Charlotte Lohmann, SVP General Counsel

      • Monika Bähner

        Monika Bähner, Senior Director Search and Evaluation

        • Harald Watzka

          Harald Watzka, VP Research and Development Alliance Management

          LocationsView all

          2 locations detected

          • Planegg, BY HQ

            Germany

            Semmelweisstraße 7

          • Boston, MA

            United States

            470 Atlantic Ave #1401

          MorphoSys Financials

          Summary Financials

          Revenue (Q1, 2024)
          €27.5M
          Gross profit (Q1, 2024)
          €26.6M
          Net income (Q1, 2024)
          (€311.0M)
          Cash (Q1, 2024)
          €131.3M
          EBIT (Q1, 2024)
          (€265.5M)

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX